Policy Surveillance: the Future of Scientific Legal Mapping.

"政策监督"是指"持续、系统地收集、分析、解释和 传播有关公共卫生法律和政策的信息"（Chriqui， 奥康纳和Chaloupka 2011）。政策监测产生可靠的纵向数据， 评估法律对健康的影响;它还可以提高公众和决策者对以下问题的认识： 法律趋势，并支持推广有前途的循证政策创新。 美国国立卫生研究院（NIH）支持政策监测的发展， 计划，通过NIAAA的酒精政策信息系统（APIS）和国家癌症 学院的课。最近，NIDA资助启动了两项政策监督， 处方药滥用政策系统（PDAPS）和药物滥用政策 系统（DAPS）。疾病预防控制中心一直在增加对政策监测活动的支持， 罗伯特·伍德约翰逊基金会资助了一项政策监督计划， 提供方法和技术援助，并维持www.example.com这一总体卫生政策， 监视入口 随着越来越多的研究人员和消费者进入该领域--来自州、联邦和 在国际一级和私营工业中-术语、方法 标准，并就任何所需的治理机制达成共识， 持续增长和采用这一重要的科学过程及其有价值的产品。到 为了满足这些需求，我们建议召开一次30 - 35名受邀与会者的会议， 代表来自研究，技术和实践的实践的主要利益相关者; 编写、出版和分发至少一份总结讨论情况的报告， 与会者达成共识;并制定一年合作计划 进一步加强合作和凝聚力。

“Policy surveillance” is the “ongoing, systematic collection, analysis, interpretation and dissemination of information about a given body of public health law and policy” (Chriqui, O'Connor, and Chaloupka 2011). Policy surveillance produces reliable longitudinal data for evaluating the health effects of laws; it can also increase public and policymaker awareness of trends in the law, and support diffusion of promising and evidence-based policy innovations. The National Institutes of Health (NIH) supported the development of policy surveillance programs, through NIAAA’s Alcohol Policy Information System (APIS) and the National Cancer Institute’s CLASS. More recently, NIDA has funded the launch of two policy surveillance programs, the Prescription Drug Abuse Policy System (PDAPS) and the Drug Abuse Policy System (DAPS). CDC has been increasing its support for policy surveillance activities, and the Robert Wood Johnson Foundation has funded a Policy Surveillance Program to provide methodological and technical assistance, and maintain LawAtlas.org, a general health policy surveillance portal. As more and more researchers and consumers enter the field — from the state, federal and international levels and in private industry — harmonization of terms, methodological standards, and consensus on any needed governance mechanisms is valuable to ensure continued growth and adoption of this important scientific process and its valuable products. To meet these needs, we propose to convene one conference of 30-35 invited attendees who represent the practice’s primary stakeholders from across research, technology and practice; develop, publish and disseminate at least one report that summarizes the discussion and consensus reached among attendees; and establish a one-year plan of collaborative work towards further cooperation and cohesion.